Reproductive rights groups sue FDA over EC

Article

The Center for Reproductive Rights filed a lawsuit against the acting commissioner of the Food and Drug Administration in January for failing to approve an emergency contraceptive (EC) for over-the-counter access.

The Center for Reproductive Rights filed a lawsuit against the acting commissioner of the Food and Drug Administration in January for failing to approve an emergency contraceptive (EC) for over-the-counter access. The lawsuit was filed hours after the FDA decided it would delay a decision to make the EC product Plan B available to women aged 16 and older without a prescription.

Last year, the FDA rejected a similar request to make Plan B available without a prescription to women of all ages. The FDA cited a lack of information on whether the EC could be taken safely by women under the age of 16 and whether it would promote risky sexual behavior.

In response, Plan B's manufacturer modified its application for over-the-counter status by limiting access to those aged 16 or older. The FDA responded by delaying its decision.

Recent Videos
Supreme Court upholds mifepristone access: Implications for women's health | Image Credit: linkedin.com
The significance of the Supreme Court upholding mifepristone access | Image Credit: unchealth.org
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
© 2024 MJH Life Sciences

All rights reserved.